EP05.02-003 Durvalumab after Chemoradiotherapy (CRT) in Unresectable Stage III NSCLC. Comparative Study of Two Cohorts in the Real-World Setting

  1. Tavara, B.
  2. Rojas, M.
  3. Rodríguez, Z.
  4. Garrido, M.L.
  5. López, L.
  6. Medina, S.
  7. Ponte, C.
  8. López, A.
  9. Sanchez, E.
  10. Pedraza, M.
  11. Viñals, P.
  12. Lopez, M.
  13. Alonso, D.
  14. Rodríguez, A.
  15. Castañon, C.
  16. Davila, E.
  17. De Sande, L.M.
  18. Nieto, B.
  19. Vallejo Pascual, M.E. 1
  20. Rodriguez, J.d.l.R.
  21. Garcia Palomo, A.
  22. Diz Taín, P.
  1. 1 Universidad de León
    info

    Universidad de León

    León, España

    ROR https://ror.org/02tzt0b78

Journal:
Journal of Thoracic Oncology

ISSN: 1556-0864

Year of publication: 2022

Volume: 17

Issue: 9

Pages: S283-S284

Type: Article

DOI: 10.1016/J.JTHO.2022.07.485 GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Journal of Thoracic Oncology